The sticker shock for Horizon Pharma's Vimovo drug is magnified by the fact that the painkiller's two main ingredients can be purchased separately -- for just $36. A spokesman for Dublin-based Horizon said that the $2,979 wholesale price does not reflect "the cost to patients or the cost to the system." Horizon estimates that 98% of all insured Vimovo patients pay $10 or less out of pocket. The day after Trump's speech, Horizon (HZNP) raised the average wholesale price on Vimovo by 9.9% to $2,979 per bottle. "What you see between the gross price and net price is a big bubble -- and we don't know where the savings are passed on to," Samimy said.

Source: CNN February 15, 2018 18:11 UTC